SCHEMBL687339

SCHEMBL687339

O=C(O)C[C@H](NC(=O)Nc1c(O)ccn(Cc2ccccc2Cl)c1=O)c1ccc(OC(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PTGER3 P43115 12/20 0.39
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
MAPT P10636 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KCNJ5 P48544 1/20 0.36
KCNJ3 P48549 1/20 0.36
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688178 0.93 PTGER3 (0.42) PTGER3MAPTKDM4EALDH1A1MAPK1
SCHEMBL687524 0.90 PTGER3 (0.45) PTGER3MAPTKDM4EALDH1A1MAPK1
SCHEMBL687418 0.90 PTGER3 (0.46) PTGER3KDM4EALDH1A1MAPK1SMN1; SMN2
SCHEMBL688306 0.89 MAPT (0.51) PTGER3ITGB1ITGA4MAPTKDM4E
SCHEMBL687238 0.89 PTGER3 (0.46) PTGER3MAPTKDM4EALDH1A1MAPK1
SCHEMBL688004 0.89 PTGER3 (0.44) PTGER3KDM4EALDH1A1MAPK1SMN1; SMN2
SCHEMBL688158 0.89 RXFP1 (0.45) PTGER3ITGB1ITGA4MAPTKDM4E
SCHEMBL688040 0.87 PTGER3 (0.49) PTGER3MAPTKDM4EALDH1A1MAPK1
SCHEMBL688155 0.87 PTGER3 (0.49) PTGER3MAPTKDM4EALDH1A1MAPK1
SCHEMBL687043 0.87 CTSA (0.45) PTGER3MAPTKDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed